LIMK1 is highly expressed by colon cancer tissues, and inhibiting the expression of LIMK1 can reduce the proliferation, invasion and epithelial–mesenchymal transition of colon cancer cells by interacting with STK25 [59]. Here, STK25 is linked to colonic neoplasm.